Obzen's annual revenue fell sharply from KRW 25.93 billion in 2022 to KRW 16.99 billion in 2023, then recovered to KRW 15.20 billion in 2024 and KRW 23.41 billion in 2025, up roughly 54% year over year.
Operating profit was negative for three consecutive years — KRW -2.05 billion in 2022, KRW -5.83 billion in 2023, and KRW -4.15 billion in 2024 — before turning positive at KRW 6.37 million in 2025.
However, net loss attributable to owners remained similar in scale, at KRW -3.43 billion in 2025 versus KRW -3.28 billion in 2024, reflecting non-operating, non-cash factors such as derivative valuation losses related to convertible bonds.
Total equity grew from a near-impairment level of KRW 106 million in 2022 to KRW 8.20 billion in 2023, KRW 9.99 billion in 2024, and KRW 10.50 billion (owners' equity) in 2025, yet the debt ratio swung widely — from 9,839.0% in 2022 down to 132.1% in 2023 and 195.0% in 2024, then back up to 410.5% in 2025 — indicating significant volatility in the capital structure.
On a quarterly basis, revenue was KRW 6.52 billion with operating profit of KRW 744 million in 2025 Q2, narrowing to KRW 6.34 billion revenue and KRW 120 million operating profit in 2025 Q3. Revenue then surged to KRW 13.09 billion in 2026 Q1, but the company swung back to an operating loss of KRW 465 million.
In 2026 Q2, revenue was KRW 12.51 billion with an operating loss of KRW 650 million — revenue expanded substantially year over year, but operating losses persisted, likely reflecting both the scale effect from the Zalesia merger and temporary cost increases.
Operating cash flow (CFO) turned positive at KRW 2.26 billion in 2025, an improvement versus the negative cash flows seen in 2023 and 2024.